Showing results (41-50 of 84) with videos related to
Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 1998
Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesteraseS M Guichard, C L Morton, E J Krull, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Escalating systemic exposure of continuous infusion topotecan in children with recurrent acute leukemiaW L Furman, S D Baker, C B Pratt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Effective schedules of exposure of medulloblastoma and rhabdomyosarcoma xenografts to topotecan correlate with in vitro assaysC A Pawlik, P J Houghton, C F Stewart, et al.European Journal of Clinical Pharmacology|January 1, 1986
The effect of ranitidine and cimetidine on imipramine dispositionB G Wells, J A Pieper, T H Self, et al.Lancet (London, England)|February 18, 1984
Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemiaW E Evans, W R Crom, C F Stewart, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Disposition of total and unbound etoposide following high-dose therapyT L Schwinghammer, R A Fleming, C S Rosenfeld, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft modelsD S Middlemas, C F Stewart, M N Kirstein, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastomaW C Zamboni, A J Gajjar, R L Heideman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group StudyR L Saylors, C F Stewart, W C Zamboni, et al.Cancer Chemotherapy and Pharmacology|September 27, 2014
Phase I dose escalation and pharmacokinetic study of oral gefitinib and irinotecan in children with refractory solid tumorsR C Brennan, W Furman, S Mao, et al.Pageof 9